Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis

Imatinib mesylate is a targeted therapy that acts by inhibiting tyrosine kinase of the bcr-abl fusion oncoprotein, which is specific to chronic myeloid leukemia (CML), and the c-transmembrane receptor, which is specific to gastrointestinal stromal tumors. Interstitial pneumonitis is a rare adverse e...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Go, Seong Woo, Kim, Boo Kyeong, Lee, Sung Hak, Kim, Tae-Jung, Huh, Joo Yeon, Lee, Jong Min, Hah, Jick Hwan, Kim, Dong Whi, Cho, Min Jung, Kim, Tae Wan, Kang, Ji Young
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884114/
https://ncbi.nlm.nih.gov/pubmed/24416057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2013.75.6.256
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi